Telemedicine to Diagnose and Treat Dysphagia in COVID Patients

Dysphagia, swallowing difficulties n patients with COVID-19 should be diagnosed and treated by telemedicine to lessen the risk to health care professionals, reports a new study.

Dysphagia, swallowing difficulties n patients with COVID-19 should be diagnosed and treated by telemedicine to lessen the risk to health care professionals, reports a new study. The findings of the study are published in the journal Archives of Physical Medicine and Rehabilitation.

COVID-19 and SARS-CoV-2, the virus behind the disease, have caused health care providers to change how they treat patients. Clinicians are now frequently using telemedicine to see their patients for routine checkups, saving office visits for emergencies. The same goes for rehabilitation. For example, researchers are looking for ways to improve the screening, assessment, and treatment of patients with COVID-19 and dysphagia -- swallowing difficulties -- by doing it remotely.

Difficulty Swallowing / Dysphagia - Symptom Evaluation
Difficulty with swallowing or dysphagia is a problem, which if left untreated, could cause malnutrition and seriously affect the patient. Treatment of dysphagia depends on the underlying cause.

‘Although vast improvements in telemedicine for dysphagia have been made in recent years, patients continue to be limited in their ability to receive effective remote care. ’

Health care professionals whose work puts them in contact with the body areas frequented by SARS-CoV-2 -- such as the nose, mouth, and airway -- share a responsibility for engaging patients in a manner that won't add to the spread of COVID-19. Risks need to be weighed before screenings, assessments, and treatments are undertaken.

Ideally, clinicians assess dysphagia through a clinical (bedside) evaluation and one of two standard tests: a videofluoroscopic swallow study or a flexible endoscopic evaluation of swallowing. These exams determine swallowing ability, look for changes in the anatomy and movements of the larynx and tongue, analyze airway vulnerability, and measure other characteristics related to swallowing physiology.

However, during the pandemic, clinicians diagnosing and treating dysphagia in COVID-19 patients are putting themselves at risk by using these up close and physical techniques. And simply relying on methods such as medical history reviews and patient reporting of symptoms is not enough.

Social Media Users Belief In Covid-19 Misinformation
People who rely on social media as their primary news source are more likely to believe misinformation about the pandemic, according to researchers.

"The irony is that patients with COVID-19, especially those who were recently removed from mechanical ventilation in intensive care units, may be among those who most need the clinical and instrumental exams for properly and comprehensively assessing dysphagia," says Martin B. Brodsky, Ph.D., Sc.M., associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine.

Therefore, in an editorial in the September 2020 issue of the Archives of Physical Medicine and Rehabilitation, Brodsky and colleague Richard Gilbert, M.D., with the Laboratory for Biological Architecture at the Providence VA Medical Center, say it's time to embrace telemedicine for dysphagia.

Study Details New Way to Identify Patients at Risk of Dysphagia After Head and Neck Cancer Treatment
Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study

"To make that happen, there needs to be continued engagement by clinicians with third-party payers -- including insurance companies, and state and federal government programs such as Medicare -- to get support, acceptance and financial coverage for the use of telemedicine in this way," he explains.

Treating dysphagia remotely is not new, having been researched and practiced (to a smaller extent) for nearly 20 years. However, more widespread use had previously been hampered by technological difficulties, the high expense of equipment, lack of standardized training, and billing and coverage issues.

How to Deal With Dengue During the COVID-19 Pandemic?
The overlapping symptoms of dengue and COVID-19 infection makes it difficult to distinguish between the two. Besides, a lack of a vaccine or specific antiviral treatment for both diseases makes dengue a double whammy during the COVID-19 pandemic.

That all changed, Brodsky says, with the arrival of COVID-19.

"Although vast improvements in telemedicine for dysphagia have been made in recent years, patients continue to be limited in their ability to receive effective remote care," Brodsky says. "With the current pandemic, we need that to change because the traditional clinical and instrumental exams used for assessing dysphagia are putting health care workers who treat patients with COVID-19 at risk for contracting and further spreading the disease."

"We need innovative thinking and technologies to be rapidly translated into clinical practice to enable telemedicine services for dysphagia -- now, more than ever," adds Brodsky.

Source-Eurekalert